Indocyanine Green Angiography Findings in Acute Retinal Necrosis Syndrome.

Détails

ID Serval
serval:BIB_3A1EEB45C996
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Indocyanine Green Angiography Findings in Acute Retinal Necrosis Syndrome.
Périodique
Klinische Monatsblatter Fur Augenheilkunde
Auteur⸱e⸱s
Bissig A., Balaskas K., Vaudaux J.D., Guex-Crosier Y.
ISSN
1439-3999 (Electronic)
ISSN-L
0023-2165
Statut éditorial
Publié
Date de publication
2011
Peer-reviewed
Oui
Volume
228
Numéro
4
Pages
334-336
Langue
anglais
Notes
Publication types: JOURNAL ARTICLEPublication Status: ppublish
Résumé
BACKGROUND: Acute retinal necrosis syndrome is clinically defined by the presence of peripheral necrotizing retinitis associated with severe occlusive vasculitis caused primarily by herpes simplex virus and varicella zoster virus. Previously considered as an exclusively retinal pathology, choroidal involvement, as demonstrated by indocyanine green angiography, has not been extensively studied. HISTORY AND SIGNS: Indocyanine green angiography was performed in 4 patients with ARN. Observed angiographic patterns included: 1. a characteristic triangular area of hypo-perfusion, 2. hypofluorescent lobular patches and areas of fuzzy choroidal vascular hyperfluorescence, and 3. isolated hypofluorescent lobular patches of the contralateral eye. THERAPY AND OUTCOME: Marked choroidal hypo-perfusion on indocyanine green angiography was associated with extensive retinal ischemia. Treatment included a combination of antiviral agents and corticosteroids complemented by prophylactic acetylsalicylate. CONCLUSION: Indocyanine green angiography may provide important information regarding choroidal vascular involvement in ARN. It may also permit the timely identification of sub-clinical contralateral eye involvement.
Pubmed
Web of science
Création de la notice
18/04/2011 19:17
Dernière modification de la notice
20/08/2019 13:29
Données d'usage